Ingevity Corp (NGVT) PT Raised to $87 at Stifel

Stifel analyst Vicent Anderson raised the price target on Ingevity Corp (NYSE: NGVT) to $87.00 (from $81.00) while maintaining a Buy rating.

The analyst comments "We are adjusting our estimates following Ingevity's 4Q20 conference call. We maintain our Buy rating and raise our target price to $87 from $81 as we introduce preliminary 2022 estimates. Overall, we believe Ingevity has pointed to growth areas that carry real opportunity. Combined with what is likely overly negative sentiment toward activated carbon demand, and cyclical upside across the remaining business, we continue to view Ingevity as an attractive investment."

You May Also Be Interested In

• Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
• Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
• Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'